Martin Kaiser
banner
mymkaiser.bsky.social
Martin Kaiser
@mymkaiser.bsky.social
Haemato-oncologist and myeloma researcher; genetics, imaging and more for patient-centric care. Vice-chair UK NCRI Myeloma Trials. EHA European Affairs. Interested in access and HTA. Academic nomad.
Reposted by Martin Kaiser
🧬 Some promising novel candidates for therapeutic inhibition included:
• BAFF-R and CD39 in HL
• CD25 in MM
• CD27 in CLL
• CD80/86 in DLBCL
• CCR2 in FL and MZL
April 16, 2025 at 11:52 AM
Meanwhile, some voting districts (Berlin-Mitte, of all !🙄) did not manage to send out election materials to voters abroad on time. Certainly not an important feature given the high % of votes casted (which is great) but still disappointing re active democratic participation.
February 24, 2025 at 6:49 AM
Literally just cleaned survival data for a Sunday R analysis...
January 26, 2025 at 11:54 AM
Which are also not covered for visiting students from EU funders (at least NHS fee not covered by @dfg.de ), making it comfy for junior researchers 🙃
January 23, 2025 at 8:32 AM
Did this a few years ago. Consider watching Wolf Hall as easy going prep. Knowing the names of the Henry VIII's wifes seemed to answer 50% of questions.
January 11, 2025 at 12:16 PM
Would be great if you could add me scholar.google.com/citations?us...
November 29, 2023 at 10:10 PM